Page last updated: 2024-10-27

fluconazole and Necrotizing Pyelonephritis

fluconazole has been researched along with Necrotizing Pyelonephritis in 10 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C."7.71Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001)
"We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis."7.70Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999)
"In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C."3.71Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001)
"We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis."3.70Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999)
"Pyelonephritis was associated with caliectasis and obstruction due to possible fungus ball formation."2.82Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature. ( Kolonitsiou, F; Lekkou, A; Paliogianni, F; Spiliopoulou, A; Tsoupra, S; Vrioni, G, 2022)
"Fluconazole is an effective and less toxic alternative to prolonged courses of amphotericin B in the treatment of neonatal renal candidiasis."1.29Neonatal renal candidiasis. ( Bailey, CJ; Cartledge, JM; Morris, SA, 1994)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's5 (50.00)18.2507
2000's3 (30.00)29.6817
2010's0 (0.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Spiliopoulou, A1
Kolonitsiou, F1
Vrioni, G1
Tsoupra, S1
Lekkou, A1
Paliogianni, F1
Kamaliah, MD1
Bhajan, MA1
Dzarr, GA1
Etienne, M1
Caron, F1
Morris, SA1
Bailey, CJ1
Cartledge, JM1
Nomura, J1
Ruskin, J1
Vorreuther, R1
Kuss, M1
Franzen, W1
Engelking, R1
Altenburg, A1
Kernbaum, S1
Chiche, R1
Desgrez, JP1
Le Goaziou, F1
Le Houelleur, J1
Louie, A2
Liu, W2
Miller, DA1
Sucke, AC1
Liu, QF1
Drusano, GL1
Mayers, M1
Miller, MH2
Kaw, P1
Banerjee, P1
Chen, G1
Perfect, JR1
Savani, DV1
Durack, DT1

Reviews

2 reviews available for fluconazole and Necrotizing Pyelonephritis

ArticleYear
Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature.
    Journal de mycologie medicale, 2022, Volume: 32, Issue:2

    Topics: Adult; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; COVID-19; Fluconazole; Humans

2022
[Management of fungal urinary tract infections].
    Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:12 Pt 3

    Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; D

2007

Other Studies

8 other studies available for fluconazole and Necrotizing Pyelonephritis

ArticleYear
Emphysematous pyelonephritis caused by Candida infection.
    The Southeast Asian journal of tropical medicine and public health, 2005, Volume: 36, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Diabetes Mellitus, T

2005
Neonatal renal candidiasis.
    Journal of paediatrics and child health, 1994, Volume: 30, Issue:2

    Topics: Amphotericin B; Candidiasis; Diagnostic Imaging; Drug Therapy, Combination; Fluconazole; Humans; Inf

1994
Failure of therapy with fluconazole for candidal endophthalmitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:5

    Topics: Adult; Amphotericin B; Candidiasis; Cross Infection; Endophthalmitis; Female; Fluconazole; Fungemia;

1993
[Gas-forming mycosis of the kidney].
    Der Urologe. Ausg. A, 1993, Volume: 32, Issue:1

    Topics: Adult; Candidiasis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fluconazole; Humans;

1993
[Candida pyelonephritis].
    Annales francaises d'anesthesie et de reanimation, 1996, Volume: 15, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazol

1996
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:12

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis;

1999
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Endocarditis; Flucon

2001
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:4

    Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immu

1986